Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 239
Filter
2.
Animal ; 14(5): 952-962, 2020 May.
Article in English | MEDLINE | ID: mdl-31735196

ABSTRACT

Low methane (CH4) emissions from sheep fed forage rape (Brassica napus) might be related to low ruminal pH value. In this study, sodium carbonate (Na2CO3: SC) was supplemented to the diet to alter ruminal pH for evaluation of its role in CH4 emissions from sheep fed forage rape. Fourteen intact and eight fistulated Romney sheep were adapted to forage rape over 32 days and then randomly allocated to one of two groups: diets supplemented with SC or not (control). Methane emissions were measured from intact sheep in seven experimental periods. In parallel, ruminal pH and fermentation characteristics were assessed using the fistulated sheep. In the first (P01) and the second (P02) periods, none of the sheep received SC to examine the baseline CH4 emissions. The P01 period was used as a covariate for analysis of gas emission measurements in subsequent measurement periods. Sodium carbonate was offered at 5% of the forage DM in P03 and P04, increased to 8% in P05 and P06 to assess the effect of pH increase on CH4 emissions and stopped in P07 to assess if the CH4 emissions reverted to values similar to those measured before the supplementation started. Methane yield (g/kg forage DM intake) was similar for the sheep in both groups during P02 and P03, but sheep supplemented with SC in the diet emitted 36%, 49% and 30% more CH4 per unit of forage DM intake than those in the control group during P04, P05 and P06, respectively. Emissions returned to similar levels when SC supplementation was ceased in P07. Ruminal pH was 0.412 to 0.565 units higher in SC supplemented sheep than for the control group during the SC treatment periods. Based on the lack of an immediate response in CH4 emissions to the supplementation of SC in P03, the positive responses in P04 to P06 and the rapid disappearance of the response after supplementation with SC stopped in P07, we propose a new hypothesis that ruminal pH effects on CH4 emissions are possibly through medium-term changes in microbial and methanogenic communities in the rumen, rather than a direct, short-term impact on methanogens per se. In conclusion, SC supplemented to the forage rape diet of sheep increased rumen pH, leading to an increase in CH4 emissions. Low ruminal pH in sheep fed forage rape explains, at least partially, the reported low CH4 emissions from sheep fed with this forage crop.


Subject(s)
Brassica napus , Methane , Sheep , Animal Feed/analysis , Animals , Diet/veterinary , Dietary Supplements/analysis , Digestion , Fermentation , Hydrogen-Ion Concentration , Methane/metabolism , Rumen/metabolism , Sheep/physiology
3.
Am J Trop Med Hyg ; 99(3): 749-752, 2018 09.
Article in English | MEDLINE | ID: mdl-30014821

ABSTRACT

Onchocerciasis is a neglected tropical disease targeted for elimination. The World Health Organization (WHO) has developed guidelines for the verification of onchocerciasis elimination that include entomological and epidemiological criteria. The latter require demonstrating with statistical confidence that the infection prevalence in children is less than 0.1%, necessitating an assay with a high degree of specificity. We present an analysis of the performance of the Onchocerciasis Elimination Program for the Americas (OEPA) version of the Ov16 enzyme-linked immunosorbant assay (ELISA) when used under operational conditions. In Africa and Latin America, the assay demonstrated 99.98% specificity in 69,888 children in 20 foci where transmission was believed to be interrupted. The assay produced a prevalence estimate equal to that of skin snip microscopy when applied in putatively hypo-endemic zones of Ethiopia. The OEPA Ov16 ELISA demonstrated the specificity required to be effectively deployed to verify transmission elimination under the WHO guidelines, while exhibiting a sensitivity equivalent to skin snip microscopy to identify hypo-endemic areas.


Subject(s)
Ivermectin/administration & dosage , Ivermectin/therapeutic use , Mass Drug Administration , Onchocerca volvulus , Onchocerciasis/drug therapy , Animals , Antibodies, Helminth , Child , Disease Eradication , Enzyme-Linked Immunosorbent Assay , Global Health , Humans , Seroepidemiologic Studies , Time Factors
4.
J Anim Sci ; 95(9): 3905-3913, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28991992

ABSTRACT

Selection lines of sheep with low and high CH yield (g/kg DMI; CH/DMI) are being developed on the basis of feeding pelleted alfalfa hay at 2.0 times maintenance ME requirements in respiration chambers, but their divergence under predominant grazing conditions, as in New Zealand, is not known. The objectives of this study were to determine CH emissions and rumen fermentation characteristics in sheep from low and high CH/DMI selection lines while grazing pasture. Two grazing experiments were conducted with 42 selection line ewes in March 2013 (Exp. 1) and 98 selection line progeny ewe hoggets in October/November 2014 (Exp. 2), with CH emissions estimated by the SF tracer technique and DMI estimated by titanium oxide in combination with natural long-chain -alkanes. Total daily CH production (g/d) was similar between high and low CH/DMI selection line sheep in Exp. 1 and lower for low CH/DMI progeny compared with high CH/DMI progeny in Exp. 2 ( < 0.05). The CH/DMI tended to be 20% lower for low CH/DMI line sheep compared with high CH/DMI selection line sheep in Exp. 1 ( < 0.10) and was 15% lower for the low CH/DMI line in Exp. 2 ( < 0.01). Total VFA concentration and concentrations (m) of acetate, butyrate, and isobutyrate plus isovalerate were lower ( < 0.05) for low CH/DMI line sheep compared with high CH/DMI selection line sheep in both experiments. The current study indicates that differences in CH/DMI and VFA concentrations in selection line sheep, previously established on alfalfa pellets, are also present to a similar magnitude when grazing pasture.


Subject(s)
Animal Feed/analysis , Medicago sativa , Methane/metabolism , Sheep/physiology , Agriculture/methods , Animals , Diet/veterinary , Female , Fermentation , New Zealand , Random Allocation , Rumen/metabolism , Selection, Genetic
5.
Hum Immunol ; 75(6): 578-83, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24530823

ABSTRACT

Role of donor specific antibodies (DSAs) in liver allograft function has not been fully defined. We report an ABO compatible orthotopic liver transplant case with DSAs to donor HLA, where the patient developed immediate antibody-mediated rejection (AMR).The patient, a 43-year-old female with cirrhosis, underwent ABO-compatible living-donor liver transplant from her husband. On post-operative day (POD)1, serum transaminases were sharply elevated. Retrospective testing of pre-transplant serum demonstrated presence of strong class I and class II anti-HLA antibodies and positive T- and B-cell flow-cytometric crossmatches (FCXM). Transaminase levels improved with plasmapheresis and thymoglobulin. On POD7, her liver enzymes became elevated again and allograft biopsy stained positive for C4d. Patient was treated with intravenous immunoglobulin and rituximab and recovered over time. Pre-transplant sera of patient were retrospectively tested by C1q assay to determine the cytotoxic function of DSAs; DSAs were positive for C1q binding. Our results suggest that pre-liver transplant antibody testing may be helpful in identifying patients at risk for development of AMR.


Subject(s)
ABO Blood-Group System/immunology , Autoantibodies/blood , Graft Rejection/immunology , HLA Antigens/immunology , Isoantibodies/blood , Liver Transplantation , Living Donors , Adult , B-Lymphocytes/immunology , B-Lymphocytes/pathology , Complement C4b , Female , Graft Rejection/pathology , Graft Rejection/therapy , Histocompatibility Testing , Humans , Immunoglobulins, Intravenous/therapeutic use , Liver Cirrhosis/immunology , Liver Cirrhosis/pathology , Liver Cirrhosis/surgery , Male , Peptide Fragments/blood , Plasmapheresis , Spouses , T-Lymphocytes/immunology , T-Lymphocytes/pathology , Transaminases/blood , Transplantation, Homologous
6.
Am J Transplant ; 13(10): 2577-89, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23941128

ABSTRACT

Reports have associated non-HLA antibodies, specifically those against angiotensin II type-1 receptor (AT1R), with antibody-mediated kidney graft rejection. However, association of anti-AT1R with graft failure had not been demonstrated. We tested anti-AT1R and donor-specific HLA antibodies (DSA) in pre- and posttransplant sera from 351 consecutive kidney recipients: 134 with biopsy-proven rejection and/or lesions (abnormal biopsy group [ABG]) and 217 control group (CG) patients. The ABG's rate of anti-AT1R was significantly higher than the CG's (18% vs. 6%, p < 0.001). Moreover, 79% of ABG patients with anti-AT1R lost their grafts (vs. 0%, CG), anti-AT1R levels in 58% of those failed grafts increasing posttransplant. With anti-AT1R detectable before DSA, time to graft failure was 31 months-but 63 months with DSA detectable before anti-AT1R. Patients with both anti-AT1R and DSA had lower graft survival than those with DSA alone (log-rank p = 0.007). Multivariate analysis showed that de novo anti-AT1R was an independent predictor of graft failure in the ABG, alone (HR: 6.6), and in the entire population (HR: 5.4). In conclusion, this study found significant association of anti-AT1R with graft failure. Further study is needed to establish causality between anti-AT1R and graft failure and, thus, the importance of routine anti-AT1R monitoring and therapeutic targeting.


Subject(s)
Autoantibodies/blood , Graft Rejection/immunology , Graft Survival , Kidney Transplantation , Receptor, Angiotensin, Type 1/immunology , Adult , Autoantibodies/immunology , Biopsy , Case-Control Studies , Enzyme-Linked Immunosorbent Assay , Female , Follow-Up Studies , Graft Rejection/blood , Graft Rejection/diagnosis , Graft Rejection/mortality , HLA Antigens/immunology , Humans , Immunosuppression Therapy , Kidney Diseases/blood , Kidney Diseases/surgery , Male , Middle Aged , Prognosis , Survival Rate , Transplantation, Homologous
7.
Animal ; 7 Suppl 2: 316-21, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23739473

ABSTRACT

The objective of this study was to determine the genetic parameters of methane (CH4) emissions and their genetic correlations with key production traits. The trial measured the CH4 emissions, at 5-min intervals, from 1225 sheep placed in respiration chambers for 2 days, with repeat measurements 2 weeks later for another 2 days. They were fed in the chambers, based on live weight, a pelleted lucerne ration at 2.0 times estimated maintenance requirements. Methane outputs were calculated for g CH4/day and g CH4/kg dry matter intake (DMI) for each of the 4 days. Single trait models were used to obtain estimates of heritability and repeatability. Heritability of g CH4/day was 0.29 ± 0.05, and for g CH4/kg DMI 0.13 ± 0.03. Repeatability between measurements 14 days apart were 0.55 ± 0.02 and 0.26 ± 0.02, for the two traits. The genetic and phenotypic correlations of CH4 outputs with various production traits (weaning weight, live weight at 8 months of age, dag score, muscle depth and fleece weight at 12 months of age) measured in the first year of life, were estimated using bivariate models. With the exception of fleece weight, correlations were weak and not significantly different from zero for the g CH4/kg DMI trait. For fleece weight the phenotypic and genetic correlation estimates were -0.08 ± 0.03 and -0.32 ± 0.11 suggesting a low economically favourable relationship. These results indicate that there is genetic variation between animals for CH4 emission traits even after adjustment for feed intake and that these traits are repeatable. Current work includes the establishment of selection lines from these animals to investigate the physiological, microbial and anatomical changes, coupled with investigations into shorter and alternative CH4 emission measurement and breeding value estimation techniques; including genomic selection.


Subject(s)
Air Pollutants/metabolism , Methane/metabolism , Quantitative Trait, Heritable , Sheep, Domestic/genetics , Sheep, Domestic/metabolism , Animal Feed/analysis , Animal Husbandry , Animals , Eating , Female , Genetic Variation , Male , New Zealand , Respiration , Sheep, Domestic/growth & development
8.
J Surg Case Rep ; 2011(11): 9, 2011 Nov 01.
Article in English | MEDLINE | ID: mdl-24972399

ABSTRACT

We report a rare case of small bowel infarction due to superior mesenteric artery occlusion secondary to cardiac tumour embolism. To our knowledge, this has not been previously reported in the literature. This case highlights a rare case and reviews current knowledge on the subject.

9.
Am J Transplant ; 10(12): 2712-6, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21114648

ABSTRACT

Abdominal wall closure in pediatric solid organ recipients may be confounded by donor size discrepancy and structural insults from previous surgery. Here we describe the novel use of vascularized donor abdominal wall posterior rectus sheath fascia, as a composite tissue allotransplant (CTA), to achieve abdominal wall closure in a liver and double kidney pediatric recipient who could not be closed primarily due to donor/recipient size mismatch. The posterior rectus sheath fascia was procured in continuity with the liver and falciform ligament. Blood supply was achieved using the single hepatic artery anastomosis as part of the standard liver transplantation procedure. Specimens of posterior rectus sheath fascia taken on postoperative days 3 and 30 showed no signs of acute rejection. The patient succumbed to an overwhelming fungal infection on day 51, with no signs of intraabdominal involvement. The patient received no additional immunosuppression in conjunction with the posterior rectus sheath fascia allotransplant.


Subject(s)
Abdominal Wall/surgery , Fascia/transplantation , Hyperoxaluria/surgery , Kidney Failure, Chronic/surgery , Liver Transplantation/methods , Rectus Abdominis/transplantation , Abdomen/surgery , Child, Preschool , Fatal Outcome , Humans , Kidney Transplantation/methods , Liver/surgery , Male , Surgical Flaps/blood supply
11.
Am J Transplant ; 9(8): 1957-60, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19522875

ABSTRACT

Combined liver-kidney transplantation has become a common practice for the treatment of patients with concurrent end-stage renal disease and end-stage liver disease. Liver transplantation in the setting of multiorgan transplantation is thought to have a protective effect against humoral rejection even when a positive crossmatch is obtained prior to surgery. In most centers, a pre liver-kidney transplant crossmatch is rarely performed because of the known immunoprotective effect of the liver allograft. In this report, a case of acute humoral rejection in the kidney allograft after a combined liver-kidney transplant is described. Although humoral rejection was treated using plasmapheresis, intravenous immunoglobulin and rituximab, the kidney required 3 months to recover function and finally progressed to chronic allograft nephropathy. A heightened index of suspicion for acute humoral rejection of the renal allograft is necessary when performing combined liver-kidney transplants to highly sensitized patients due to previous organ transplants.


Subject(s)
ABO Blood-Group System/immunology , Graft Rejection/diagnosis , Graft Rejection/immunology , Histocompatibility/immunology , Immunity, Humoral/immunology , Kidney Transplantation/immunology , Liver Transplantation/immunology , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Murine-Derived , Graft Rejection/therapy , Humans , Immunoglobulins, Intravenous/therapeutic use , Immunologic Factors/therapeutic use , Kidney Failure, Chronic/surgery , Liver Diseases/surgery , Male , Middle Aged , Plasmapheresis , Rituximab , Treatment Outcome
12.
Am J Transplant ; 9(5): 1237-42, 2009 May.
Article in English | MEDLINE | ID: mdl-19422349

ABSTRACT

In October 2005, the United Network for Organ Sharing (UNOS) implemented a revised allocation policy requiring that renal allografts from young deceased donors (DDs) (<35 years old) be offered preferentially to pediatric patients (<18 years old). In this study, we compare the pre- and postpolicy quarterly pediatric transplant statistics from 2000 to 2008. The mean number of pediatric renal transplants with young DDs increased after policy implementation from 62.8 to 133 per quarter (p < 0.001), reflecting a change in the proportion of all transplants from young DDs during the study period from 0.33 to 0.63 (p < 0.001). The mean number of pediatric renal transplants from old DDs (> or =35 years old) decreased from 22.4 to 2.6 per quarter (p < 0.001). The proportion of all pediatric renal transplants from living donors decreased from 0.55 to 0.35 (p < 0.001). The proportion from young DDs with five or six mismatched human leukocyte antigen (HLA) loci increased from 0.16 to 0.36 (p < 0.001) while those with 0 to 4 HLA mismatches increased from 0.18 to 0.27 (p < 0.001). Revision of UNOS policy has increased the number of pediatric renal transplants with allografts from young DDs, while increasing HLA-mismatched allografts and decreasing the number from living donors.


Subject(s)
Kidney Transplantation/statistics & numerical data , Resource Allocation/trends , Tissue Donors/statistics & numerical data , Adult , Cadaver , Child , HLA Antigens/immunology , Histocompatibility Testing , Humans , Kidney Transplantation/immunology , Patient Selection , Resource Allocation/methods , Transplantation, Homologous
13.
Psychol Med ; 39(6): 967-76, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19091161

ABSTRACT

BACKGROUND: There are multiple models of mental illness that inform professional and lay understanding. Few studies have formally investigated psychiatrists' attitudes. We aimed to measure how a group of trainee psychiatrists understand familiar mental illnesses in terms of propositions drawn from different models. METHOD: We used a questionnaire study of a sample of trainees from South London and Maudsley National Health Service (NHS) Foundation Trust designed to assess attitudes across eight models of mental illness (e.g. biological, psychodynamic) and four psychiatric disorders. Methods for analysing repeated measures and a principal components analysis (PCA) were used. RESULTS: No one model was endorsed by all respondents. Model endorsement varied with disorder. Attitudes to schizophrenia were expressed with the greatest conviction across models. Overall, the 'biological' model was the most strongly endorsed. The first three components of the PCA (interpreted as dimensions around which psychiatrists, as a group, understand mental illness) accounted for 56% of the variance. Each main component was classified in terms of its distinctive combination of statements from different models: PC1 33% biological versus non-biological; PC2 12% 'eclectic' (combining biological, behavioural, cognitive and spiritual models); and PC3 10% psychodynamic versus sociological. CONCLUSIONS: Trainee psychiatrists are most committed to the biological model for schizophrenia, but in general are not exclusively committed to any one model. As a group, they organize their attitudes towards mental illness in terms of a biological/non-biological contrast, an 'eclectic' view and a psychodynamic/sociological contrast. Better understanding of how professional group membership influences attitudes may facilitate better multidisciplinary working.


Subject(s)
Attitude of Health Personnel , Mental Disorders/psychology , Physicians/psychology , Psychiatry , Adult , Age Factors , Female , Humans , Internship and Residency , Male , Middle Aged , Models, Biological , Pilot Projects , Principal Component Analysis , Schizophrenic Psychology , Surveys and Questionnaires , United Kingdom
14.
Transplant Proc ; 40(5): 1747-50, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18589185

ABSTRACT

INTRODUCTION: Kidneys from donors affected by autosomal-dominant polycystic kidney disease (ADPKD) are in general considered unsuitable for transplantation. To the best of our knowledge, only 12 cases of ADPKD transplanted renal units have been reported in the English literature; most have only short-term follow-up. METHODS: We provide a review of these patients and share our experience with an ADPKD patient who received a 21-year-old deceased donor ADPKD-affected renal transplant and has been closely followed for 15 years. Based on the current literature, this report is the longest follow-up of a ADPKD donor transplant. RESULTS: Over the 15-year follow-up period, there have been no complications related to the ADPKD-affected donor kidney, including three kidney transplant biopsies. The graft continues to function well with the serum creatinine currently 1.2 mg/dL. Serial axial imaging has demonstrated that the cystic disease has slowly progressed in the donor renal unit, with the largest cyst having only increasing from 1.2 to 2.9 cm in diameter. Metachronous, bilateral laparoscopic nephrectomies of the native kidneys were performed owing to intractable pain from cystic enlargement. CONCLUSIONS: Normal functioning deceased donor kidneys that show signs of early ADPKD should be considered acceptable for donation in select cases. These organs provide the recipient a safe, reasonable period of graft survival and have not been shown to cause adverse effects.


Subject(s)
Kidney Transplantation/physiology , Polycystic Kidney, Autosomal Dominant/surgery , Adult , Cadaver , Creatinine/blood , Disease Progression , Follow-Up Studies , Humans , Male , Postoperative Complications/pathology , Tissue Donors
15.
Vet Ther ; 7(1): 27-34, 2006.
Article in English | MEDLINE | ID: mdl-16598681

ABSTRACT

Two bovine viral diarrhea virus (BVDV) fetal protection studies were done using a monovalent noncytopathic (NCP) BVDV vaccine containing type 1 BVDV. In study 1, thirty-two fetuses (23 vaccinates and nine controls) were recovered following fetal challenge with the type 1a BJ strain. Twenty of twenty-three fetuses from the vaccinates were negative for BVDV type 1 while all of the controls (nine of nine) were infected. In study 2, twenty-two animals (14 vaccinates and eight controls) were challenged with the type 2 PA131 strain. Thirteen of the fourteen fetuses from the vaccinates were negative for BVDV type 2 while all of the nonvaccinated controls (eight of eight) were infected. These results indicate the efficacy of a monovalent NCP BVDV vaccine in providing excellent protection against either BVDV type 1 or 2 fetal infection.


Subject(s)
Bovine Virus Diarrhea-Mucosal Disease/prevention & control , Diarrhea Virus 1, Bovine Viral/immunology , Diarrhea Virus 2, Bovine Viral/immunology , Infectious Disease Transmission, Vertical/veterinary , Vaccination/veterinary , Viral Vaccines/therapeutic use , Animals , Antibodies, Viral/analysis , Bovine Virus Diarrhea-Mucosal Disease/transmission , Cattle , Diarrhea Virus 1, Bovine Viral/isolation & purification , Diarrhea Virus 2, Bovine Viral/isolation & purification , Female , Infectious Disease Transmission, Vertical/prevention & control , Pregnancy , Treatment Outcome , Vaccines, Attenuated
16.
Transplant Proc ; 36(9): 2625-7, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15621107

ABSTRACT

We present our experience of using the bipolar electrocautery for division of the left renal vein branches in laparoscopic right living donor nephrectomy. This has been performed in 160 cases with no complications related to the technique. The absence of laparoscopic clips allows easier and safer placement of the endostaple.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Electrocoagulation/methods , Immunosuppressive Agents/therapeutic use , Kidney Transplantation/immunology , Recombinant Fusion Proteins/therapeutic use , Antibodies, Monoclonal/administration & dosage , Basiliximab , Child , Female , Graft Rejection/prevention & control , Humans , Immunosuppressive Agents/administration & dosage , Intraoperative Period , Male , Recombinant Fusion Proteins/administration & dosage
17.
Breast ; 13(6): 502-5, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15563858

ABSTRACT

A new technique of immediate breast reconstruction is presented. This technique uses a silicone implant placed in a subpectoral pocket, using de-epithelialised skin from the lower breast to augment the submuscular pocket, thus producing a compound myodermal flap. The technique is simple, and the resulting scar is cosmetically satisfactory; when combined with reduction mammoplasty on the opposite breast, this technique produces satisfactory breast symmetry.


Subject(s)
Breast Neoplasms/surgery , Mammaplasty , Mastectomy/methods , Female , Humans , Time Factors
18.
SELECTION OF CITATIONS
SEARCH DETAIL
...